Press release
Medications For Heart Failure Market Forecast 2025-2034: Comprehensive Analysis And Growth Opportunities
Medications For Heart Failure Market
What Is the Projected Growth of the Medications For Heart Failure Market?
The market size for heart failure drugs has seen substantial growth over the recent years. The sector, that held a value of $10.14 billion in 2024, is predicted to enhance to $10.90 billion in 2025, reflecting a compound annual growth rate (CAGR) of 7.4%. The marked growth during the historic period can be credited to a surge in cardiovascular diseases, increased diagnosis and awareness, regulatory sanctions and backing, amplified research and development expenditure on cardiovascular medications, as well as the integration of telemedicine and remote surveillance technology.
The heart failure medication market is predicted to experience substantial growth in the upcoming years, with the market size projected to reach $14.37 billion in 2029, with a compound annual growth rate of 7.2%. The projected growth during this forecast period can be linked to the rise of personalized and precision medicine, increasing global lifestyle disease burden, developments in combination therapies and fixed-dose formulations, supportive clinical evidence and revised guidelines, as well as growing urbanization. Key trends during this forecast period will include the expansion of SGLT2 inhibitors, the integration of digital health, tools for remote monitoring and AI-powered analytics, more emphasis on HFpEF treatment, and relentless research and development.
Purchase the full report for exclusive industry analysis:
https://www.thebusinessresearchcompany.com/customise?id=24315&type=smp
What Are the Different Medications For Heart Failure Market Segments?
The medications for heart failure market covered in this report is segmented -
1) By Drug Class: Angiotensin-Converting Enzyme (ACE) Inhibitors, Beta Blockers, Diuretics, Aldosterone Antagonists, Angiotensin II Receptor Blockers (ARBs), Other Drug Classes
2) By Route Of Administration: Oral, Intravenous, Other Routes Of Administration
3) By Distribution Channel: Hospital Pharmacies, Retail Pharmacies, Online Pharmacies, Other Distribution Channels
4) By Application: Hospital, Clinic, Other Applications
Subsegments:
1) By Angiotensin-Converting Enzyme (ACE) Inhibitors: Enalapril, Lisinopril, Ramipril, Captopril, Perindopril, Other Angiotensin-Converting Enzyme (ACE) Inhibitors
2) By Beta Blockers: Carvedilol, Metoprolol Succinate, Bisoprolol, Nebivolol, Other Beta Blockers
3) By Diuretics: Loop Diuretics, Thiazide Diuretics, Potassium-Sparing Diuretics, Other Diuretics
4) By Aldosterone Antagonists: Spironolactone, Eplerenone, Other Aldosterone Antagonists
5) By Angiotensin II Receptor Blockers (ARBs): Valsartan, Losartan, Candesartan, Irbesartan, Other Angiotensin II Receptor Blockers (ARBs)
6) By Other Drug Classes: Angiotensin Receptor-Neprilysin Inhibitors, Ivabradine, Sodium-Glucose Cotransporter-2 (SGLT2) Inhibitors, Hydralazine Or Isosorbide Dinitrate, Digoxin, Other Medications
Get your free sample here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=24315&type=smp
What Are the Primary Drivers Shaping the Medications For Heart Failure Market?
The increasing occurrence of cardiovascular diseases is anticipated to spur the expansion of the heart failure medications market. These conditions affect the heart and blood vessels, often causing severe problems like heart attacks and strokes. The escalation in cardiovascular diseases is mainly brought on by inactive lifestyles that detrimentally affect heart and vessel health. As more people are affected by cardiovascular disease, the desire for potent treatments intensifies, stimulating greater investment in heart failure medication. With this issue becoming more common, drug companies are turning their focus towards the development and improvement of treatments for better symptom management and improved patient results. For example, as reported in September 2024 by the Heart Failure Society of America (HFSA), a U.S. organization of heart failure specialists, roughly 6.7 million Americans over the age of 20 are currently living with heart failure (HF). This number is expected to reach 8.7 million by 2030, 10.3 million by 2040, and 11.4 million by 2050. Therefore, the heightened presence of cardiovascular diseases is championing the growth of the heart failure medications market.
Which Companies Are Leading in the Medications For Heart Failure Market?
Major companies operating in the medications for heart failure market are Merck & Co. Inc., Bayer AG, Sanofi SA, Bristol-Myers Squibb, AstraZeneca plc, Novartis AG, Eli Lilly and Company, Boehringer Ingelheim Pharmaceuticals Inc., Steris Pharma, CSPC Pharmaceutical, Hikma Pharmaceuticals PLC, Cadila Pharmaceuticals, Ionis Pharmaceuticals Inc., Valeant Pharmaceuticals International Inc., Hainan Poly Pharm. Co. Ltd., Addii Biotech, Lunan Pharmaceutical Group, Mylan Laboratories Inc., Neuracle Lifesciences Private Limited, JM Laboratories, Lexicon Pharmaceuticals.
What Are the Major Trends Shaping the Medications For Heart Failure Market?
Large corporations active in the heart failure medication market are concentrating on harnessing advanced drug technologies such as sodium-glucose cotransporter (SGLT) inhibitors. This type of medication provides an advanced approach to managing heart failure through the targeting of glucose reabsorption mechanisms, ultimately resulting in enhanced efficiency and better cardiovascular health. Lexicon Pharmaceuticals, a biopharmaceutical firm based in America, launched Inpefa (sotagliflozin) in May 2023 following approval from the Food and Drug Administration (FDA). This is a daily tablet taken orally aimed at reducing the likelihood of cardiovascular mortality, heart failure-related hospitalization, and emergency heart failure visits in adults suffering from heart failure, type 2 diabetes mellitus, chronic kidney disease, and other cardiovascular risk factors. The introduction of Inpefa, the first dual SGLT1/SGLT2 inhibitor on the market, signifies a notable achievement for Lexicon, offering a fresh treatment alternative for heart failure patients with a range of conditions.
Get the full report for exclusive industry analysis:
https://www.thebusinessresearchcompany.com/report/medications-for-heart-failure-global-market-report
What Are the Top Revenue-Generating Geographies in the Medications For Heart Failure Market?
North America was the largest region in the medications for the heart failure market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the medications for heart failure market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Frequently Asked Questions:
1. What Is the Market Size and Growth Rate of the Medications For Heart Failure Market?
2. What is the CAGR expected in the Medications For Heart Failure Market?
3. What Are the Key Innovations Transforming the Medications For Heart Failure Industry?
4. Which Region Is Leading the Medications For Heart Failure Market?
Why This Report Matters:
Competitive overview: This report analyzes the competitive landscape of the 3D imaging software market, evaluating key players on market share, revenue, and growth factors.
Informed Decisions: Understand key strategies related to products, segmentation, and industry trends.
Efficient Research: Quickly identify market growth, leading players, and major segments.
Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.
Contact Us
Europe: +44 207 1930 708,
Asia: +91 88972 63534,
Americas: +1 315 623 0293 or
Email: mailto:info@tbrc.info
Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Medications For Heart Failure Market Forecast 2025-2034: Comprehensive Analysis And Growth Opportunities here
News-ID: 4060813 • Views: …
More Releases from The Business Research Company
Seed Treatment Fungicides Market to Grow at 9.3% CAGR, Reaching $3.15 Billion by …
Use ONLINE30 for 30% savings on global market reports and stay on top of tariff updates, market trends, and economic shifts worldwide.
Seed Treatment Fungicides Market Outlook: How is the Market Expected to Grow by 2025?
Over the past few years, the market for seed treatment fungicides has seen robust growth. Its market value is projected to rise from $2.07 billion in 2024 to $2.21 billion in 2025, signifying a compound annual…
Rheology Modifiers Market Growth to be Driven by Emerging Trends | $10.92 Billio …
Stay informed on tariff shifts, macro trends, and global economic changes-use code ONLINE30 to enjoy 30% off our global market reports.
What is the Projected Market Size of the Rheology Modifiers Industry?
There has been a consistent expansion in the size of the rheology modifiers market in the past few years. The market, which was worth $8.59 billion in 2024, is projected to increase to $8.89 billion in 2025, demonstrating a compound…
Polyurethane Foam Market to Record 8.4% CAGR Growth Through 2029 | Global Analys …
Use ONLINE30 for 30% savings on global market reports and stay on top of tariff updates, market trends, and economic shifts worldwide.
Polyurethane Foam Market Outlook: How is the Market Expected to Grow by 2025?
In recent years, the size of the polyurethane foam market has experienced substantial growth. It is projected to increase from a value of $54.27 billion in 2024 to $57.26 billion in 2025, indicating a compound annual growth…
Pharmaceutical Intermediates Market Size to Reach $46.04 Billion by 2029 | Growt …
Stay informed on tariff shifts, macro trends, and global economic changes-use code ONLINE30 to enjoy 30% off our global market reports.
What is the Projected Market Size of the Pharmaceutical Intermediates Industry?
There has been consistent growth in the market size of pharmaceutical intermediates over the past few years. The market is predicted to increase from a value of $33.37 billion in 2024, up to $34.95 billion in 2025, with a compound…
More Releases for Medications
Compounding Pharmacy Market Personalizing Medications for Diverse Needs
In recent years, the global Compounding Pharmacy Market has transformed significantly, driven by evolving consumer preferences, rapid technological advancements, and an increasing focus on sustainability. Our comprehensive Compounding Pharmacy Market Research Report is your essential guide to navigate this dynamic landscape, offering actionable insights into emerging trends, growth drivers, and key opportunities for your business.
Unlock in-depth analyses of the competitive supplier landscape, demand dynamics, and market projections with…
Mymodalert - Your trusted source for Medications
Mymodalert is an online pharmacy committed to delivering the best healthcare products. This online pharmacy ensures a hassle-free consumer experience with just a few steps to ordering medications. All the medications retailed are FDA-approved for medical use. Mymodalert ensures that only quality medications are delivered to you.
Why choose Mymodalert?
· All the medications are genuine and quality products.
· …
Global Anti-Asthma Drugs Market Size, Share and Trends Analysis Report,By Type ( …
The global anti-asthma drugs market is anticipated to grow at a significant CAGR during the forecast period (2022-2028). Asthma is a chronic inflammatory lung disorder of the airways that is not communicable. The rise in the prevalence of asthma and COPD is driving the global Asthma and COPD Drugs Market's expansion. For instance, in 2019 the World Health Organization (WHO) estimates that asthma affected 262 million people and killed 46,1000 people. Furthermore,…
Universal Anti-Asthmatic Drugs Market 2021 Business Opportunities, Growth, Profi …
Syndicate Market Research recently launched a study report on the global Anti-Asthmatic Drugs market project light on the significant drifts and vigorous cannon into the evolution of the trade, which includes the restraints, market drivers, and opportunities. The report talks about the competitive environment prevailing in the Anti-Asthmatic Drugs market worldwide. The report lists the key players in the market and also provides insightful information about them such as their…
2020 Global Market Analysis on Osteoarthritis Medications Industry
This report also researches and evaluates the impact of Covid-19 outbreak on the Osteoarthritis Medications industry, involving potential opportunity and challenges, drivers and risks. We present the impact assessment of Covid-19 effects on Osteoarthritis Medications and market growth forecast based on different scenario (optimistic, pessimistic, very optimistic, most likely etc.).
The research report published by GLOBAL INFO RESEARCH is a comprehensive study of the global Osteoarthritis Medications market. The subject matter experts and team of highly-skilled…
Asthma Medications Market Growth Analysis up to 2027
Transparency Market Research (TMR) has published a new report on the asthma treatment market for the forecast period of 2019-2027. According to the report, the global asthma treatment market was valued at ~US$ 25 Bn in 2018, and is projected to expand at a CAGR of ~2% from 2019 to 2027.
Report Overview @ https://www.transparencymarketresearch.com/asthma-treatment-market.html
Overview
Asthma treatment involves two main types of medications: long-term asthma control medications and quick-relief (rescue) medications.
Asthma can…
